Provided by Tiger Fintech (Singapore) Pte. Ltd.

Royalty Pharma plc

31.11
-0.6800-2.14%
Post-market: 31.00-0.1100-0.35%19:43 EDT
Volume:7.27M
Turnover:224.94M
Market Cap:13.47B
PE:16.27
High:31.70
Open:31.30
Low:30.45
Close:31.79
Loading ...

Stock Track | Royalty Pharma Soars on Raised Full-Year Guidance Despite Q3 Revenue Miss

Stock Track
·
06 Nov 2024

Royalty Pharma reports Q3 results, raises FY guidance

seekingalpha
·
06 Nov 2024

Stock Track | Royalty Pharma Shares Jump 6% After Mixed Q3 Earnings

Stock Track
·
06 Nov 2024

Royalty Pharma Q3 2024 Adj EPS $1.04 Beats $0.93 Estimate

Benzinga
·
06 Nov 2024

BRIEF-Royalty Pharma Reports Third Quarter 2024 Results

Reuters
·
06 Nov 2024

Royalty Pharma : Expects 2024 Portfolio Receipts to Be Between $2,750 Mln to $2,800 Mln

THOMSON REUTERS
·
06 Nov 2024

Royalty Pharma Reports Third Quarter 2024 Results

THOMSON REUTERS
·
06 Nov 2024

Royalty Pharma Q3 Adjusted Ebitda USD 679 Million

THOMSON REUTERS
·
06 Nov 2024

Royalty Pharma enters $350M synthetic royalty funding agreement with Syndax

TIPRANKS
·
05 Nov 2024

BRIEF-Royalty Pharma And Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement For Niktimvo

Reuters
·
05 Nov 2024

Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo

THOMSON REUTERS
·
05 Nov 2024

Syndax Pharmaceuticals and Royalty Pharma Enter Into $350 Million Royalty Funding Agreement for Niktimvo™

THOMSON REUTERS
·
05 Nov 2024

Syndax Pharmaceuticals Inc - Niktimvo Expected to Launch in U.S. by Early Q1 2025

THOMSON REUTERS
·
05 Nov 2024

Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy

seekingalpha
·
01 Nov 2024

Why Southern, Xcel Energy And Royalty Pharma Are Winners For Passive Income

Benzinga
·
24 Oct 2024

Press Release: Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024

Dow Jones
·
17 Oct 2024

Royalty Pharma (NASDAQ:RPRX) Has Affirmed Its Dividend Of $0.21

Simply Wall St.
·
14 Oct 2024

Royalty Pharma Keeps Q4 Dividend at $0.21 per Share, Payable Dec. 10 to Shareholders of Record on Nov. 15

MT Newswires Live
·
11 Oct 2024

Press Release: Royalty Pharma Declares Fourth Quarter 2024 Dividend

Dow Jones
·
11 Oct 2024

Royalty Pharma PLC (RPRX) Q2 2024 Earnings Call Highlights: Surpassing Growth Expectations and ...

GuruFocus.com
·
10 Oct 2024